AccScience Publishing / GPD / Volume 2 / Issue 3 / DOI: 10.36922/gpd.0328
Cite this article
Journal Browser
Volume | Year
News and Announcements
View All

Control of mortality by human serum albumin

Andrew S. Johnson1 William Winlow1,2*
Show Less
1 Department of Biology, University of Napoli Federico II, 80138, Naples, Italy
2 Institute of Ageing and Chronic Diseases, University of Liverpool, Liverpool, UK
Submitted: 13 March 2023 | Accepted: 10 August 2023 | Published: 1 September 2023
© 2023 by the Author(s). This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution 4.0 International License ( )

In a fit, resting human, efficient heart function depends on sufficient return of blood to the heart. At any stage of acclimatization, whether through changes in external environment or illness, pressures in the cardiovascular system must equilibrate to ensure adequate supply of nutrients to the deep capillaries, simultaneously providing adequate osmotic pressure to the cells and systemic pressure for venous return. About 80% of colloid osmotic pressure (COP) is controlled by levels of human serum albumin (HSA), which is the ultimate, homeostatic determinant of fluid volume (FV) in all compartments of the body and is controlled by the liver. The state of cardiovascular output is regulated by COP, which is determined by HSA colloidal pressure, which has clinical significance in many areas of medicine. In COVID-19 and other diseases like Streptococcus, where albumin binding has been suspected of being in deficit, we suggest that raising available HSA binding will alleviate vulnerabilities to disease and sepsis, unlike present forms of fluid therapy (FT). In this review, we describe how HSA binds and delivers nutrients as an intermediary transporter as it circulates, being especially important in the lymphatic system. Insufficient HSA nutrient binding leads to cell stress and albumin-binding deficiency (ABD) as both colloidal pressure and nutrients change lead to symptoms of sepsis. HSA binding can be reduced because of a lack of HSA or external ligands taking up binding sites on HSA. FV also affects long-term metabolic and cardiac diseases due to incorrect pressure and nutrients. The HSA lymphatic nutrient pump therefore utilizes HSA as an intermediate transporter of nutrient and waste ligands, and their circulation is determined by the lymph rather than the cardiac output. An elevation of the whole body colloidal pressure will increase the whole body FV and subsequently trigger production of all other nutrients in blood plasma and lymph: For example, body fluid increase will decrease blood oxygen to the kidneys promoting erythropoietin release culminating in the creation of new blood cells. We provide evidence that the hepatic portal vein (HPV) is essential in the precise control of HSA, glucose, and ketone metabolism and that the HPV is the appropriate target for FT and glucose control. We propose that in a clinical situation where this method is applicable, raising HSA will alleviate the symptoms of ABD and decrease the likelihood of serious illness and death by sepsis.

Fluid therapy
  1. Johnson AS, Winlow W, 2022, The HSA lymphatic nutrient pump (HSALNP) and its critical and central importance to health. EC Pharmacol Toxicol, 10(12): 32–34.


  1. Johnson AS, Winlow W, 2021, COVID-19 vulnerabilities are intensified by declining human serum albumin levels. Exp Physiol, 107: 674–682.


  1. Levitt DG, Levitt MD, 2016, Human serum albumin homeostasis: A new look at the roles of synthesis, catabolism, renal and gastrointestinal excretion, and the clinical value of serum albumin measurements. Int J Gen Med, 9: 229–255.


  1. Johnson AS, Fatemi R, Winlow W, 2020, SARS-CoV-2 bound human serum albumin and systemic septic shock. Front Cardiovasc Med, 7: 153.


  1. Johnson AS, Polese G, Johnson M, et al., 2022, Appropriate human serum albumin fluid therapy and the alleviation of COVID-19 vulnerabilities: An explanation of the HSA lymphatic nutrient pump. COVID, 2: 1379–1395.


  1. Aldecoa C, Llau JV, Nuvials X, et al., 2020, Role of albumin in the preservation of endothelial glycocalyx integrity and the microcirculation: A review. Ann Intensive Care, 10: 85.


  1. Capozzi ME, Coch RW, Koech J, et al., 2020, The limited role of glucagon for ketogenesis during fasting or in response to SGLT2 inhibition. Diabetes, 69(5): 882–892.


  1. Zavala-Barrios B, Cérbulo-Vázquez A, García-Espinosa M, et al., 2023, The Colloido-Osmotic Pressure as a useful biomarker of fatal outcome in pregnant COVID-19 patients. medRxiv, 2023.06.29.23292050.


  1. Casey JD, Brown RM, Semler MW, 2018, Resuscitation fluids. Curr Opin Crit Care, 24(6): 512–518.


  1. Laffel L, 1999, Ketone bodies: A review of physiology, pathophysiology and application of monitoring to diabetes. Diabetes Metab Res Rev, 15: 412–426.<412:aid-dmrr72>;2-8


  1. Weaving G, Batstone GF, Jones RG, 2016, Age and sex variation in serum albumin concentration: An observational study. Ann Clin Biochem, 53: 106–111.


  1. Gom I, Fukushima H, Shiraki M, et al., 2007, Relationship between serum albumin level and aging in community-dwelling self-supported elderly population. J Nutr Sci Vitaminol (Tokyo), 53(1): 37–42.


  1. Starling EH, 1896, On the absorption of fluids from the connective tissue spaces. J Physiol, 19: 312–326.


  1. Woodcock TE, Woodcock TM, 2012, Revised Starling equation and the glycocalyx model of transvascular fluid exchange: An improved paradigm for prescribing intravenous fluid therapy. Br J Anaesth, 108(3): 384–394.


  1. Veraldi N, Vivès R, Blanchard-Rohner G, et al., 2022, Endothelial glycocalyx degradation in multisystem inflammatory syndrome in children related to COVID-19. J Mol Med (Berl), 100: 735–746.


  1. Sun JK, Sun F, Wang X, et al., 2015, Risk factors and prognosis of hypoalbuminemia in surgical septic patients. PeerJ, 3: e1267.


  1. Gupta L, James BS, 2012, 727: Hypoalbuminemia as a prognostic factor in sepsis, severe sepsis and septic shock. Crit Care Med, 40(12): 1–328.


  1. Takegawa R, Kabata D, Shimizu K, et al., 2019, Serum albumin as a risk factor for death in patients with prolonged sepsis: An observational study. J Crit Care, 51: 139–144.


  1. Soeters PB, Wolfe RR, Shenkin A, 2019, Hypoalbuminemia: Pathogenesis and clinical significance. JPEN J Parenter Enteral Nutr, 43(2): 181–193.


  1. Mantovani A, Garlanda C, 2023, Humoral innate immunity and acute-phase proteins. N Engl J Med, 388(5): 439–452.


  1. Seccombe A, Sapey E, 2018, What is the evidence base for fluid resuscitation in acute medicine? Clin Med (Lond), 18(3): 225–230.


  1. Zheng M, 2022, Serum albumin: A pharmacokinetic marker for optimizing treatment outcome of immune checkpoint blockade. J Immunother Cancer, 10: e005670.


  1. Chen Q, Lu M, Monks BR, et al., 2016, Insulin is required to maintain albumin expression by inhibiting forkhead box O1 protein. J Biol Chem, 291(5): 2371–2378.


  1. Lee H, Lee J, Shin H, et al., 2022, Association between early phase serum albumin levels and outcomes of post-cardiac arrest patients: A systematic review and meta-analysis. J Pers Med, 12: 1787.


  1. Kuller LH, Eichner JE, Orchard TJ, et al., 1991, The relation between serum albumin levels and risk of coronary heart disease in the Multiple Risk Factor Intervention Trial. Am J Epidemiol, 134(11): 1266–1277.


  1. Karthikeyan J, Rajaragupathy S, 2018, Diagnostic usefulness of serum albumin as a predictor of diabetic ketoacidosis. Indian J Crit Care Med, 22(10): 733–736.


  1. Kheir M, Saleem F, Wang C, et al., 2021, Higher albumin levels on admission predict better prognosis in patients with confirmed COVID-19. PLoS One, 16(3): e0248358.


  1. Ramadori G, 2020, Hypoalbuminemia: An underestimated, vital characteristic of hospitalized COVID-19 positive patients? Hepatoma Res, 6: 28.


  1. Islam N, Shkolnikov VM, Acosta RJ, et al., 2021, Excess deaths associated with Covid-19 pandemic in 2020: Age and sex disaggregated time series analysis in 29 high income countries. BMJ, 373: n1137.


  1. Zekri-Nechar K, Zamorano-León JJ, Segura-Fragoso A, et al., 2022, Albumin binds COVID-19 spike 1 subunit and predicts in-hospital survival of infected patients-possible alteration by glucose. J Clin Med, 11(3): 587.


  1. Turcato G, Zaboli A, Kostic I, et al., 2022, Severity of SARS-CoV-2 infection and albumin levels recorded at the first emergency department evaluation: A multicentre retrospective observational study. Emerg Med J, 39: 63–69.


  1. Aziz M, Fatima R, Lee-Smith W, et al., 2020, The association of low serum albumin level with severe COVID-19: A systematic review and meta-analysis. Crit Care, 24: 255.


  1. Violi F, Cangemi R, Romiti GF, et al., 2021, Is albumin predictor of mortality in COVID-19? Antioxid Redox Signal, 35: 139–142.


  1. Xie C, Wang S, Zhou J, et al., 2022, Albumin level as an independent predictive factor for adverse outcomes in COVID-19 patients: A retrospective cohort study. J Infect Dev Ctries, 16: 1696–1702.


  1. Abdeen Y, Kaako A, Amin ZA, et al., 2021, The prognostic effect of serum albumin level on outcomes of hospitalized COVID-19 patients. Crit Care Res Pract, 2021: 9963274.


  1. Prudente R, Franco E, Machado L, et al., 2022, Urea/albumin ratio associated with mortality in hospitalized COVID- 19 patients: A cohort study. Eur Respir J, 60(Suppl 66): 1460.


  1. Wybranowski T, Napiórkowska M, Bosek M, et al., 2022, Study of albumin oxidation in COVID-19 pneumonia patients: Possible mechanisms and consequences. Int J Mol Sci, 23(17): 10103.


  1. Georgieva E, Karamalakova Y, Arabadzhiev G, et al., 2022, Site-directed spin labeling EPR spectroscopy for determination of albumin structural damage and hypoalbuminemia in critical COVID-19. Antioxidants (Basel), 11: 2311.


  1. Iles RK, 2023, The COVID-19 antibody responses, isotypes and glycosylation: Why SARS-CoV-2 spike protein complex binding of IgG3 is potentiated in some and immuno-pathologies manifest. medRxiv, 2023.01.13.23284524.


  1. Siddiqui SS, Chakraborty N, Muzaffar SN, et al., 2022, Albumin kinetics in sepsis and COVID-19. Crit Care Explor, 4(3): e0651.


  1. Badawy M, Yasseen BA, El-Messiery RM, et al., 2021, Neutrophil-mediated oxidative stress and albumin structural damage predict COVID-19-associated mortality. Elife, 10: e69417.


  1. Sproston NR, Ashworth JJ, 2018, Role of C-reactive protein at sites of inflammation and infection. Front Immunol, 9: 754.


  1. Akkececi NS, Cetin GY, Gogebakan H, et al., 2019, The C-reactive protein/albumin ratio and complete blood count parameters as indicators of disease activity in patients with Takayasu arteritis. Med Sci Monit, 25: 1401–1409.


  1. Mey JT, Hari A, Axelrod CL, et al., 2020, Lipids and ketones dominate metabolism at the expense of glucose control in pulmonary arterial hypertension: A hyperglycaemic clamp and metabolomics study. Eur Respir J, 55(4): 1901700.


  1. Kolb H, Kempf K, Röhling M, et al., 2021, Ketone bodies: From enemy to friend and guardian angel. BMC Med, 19: 313.


  1. Cheng PC, Hsu SR, Cheng YC, 2016, Association between serum albumin concentration and ketosis risk in hospitalized individuals with Type 2 diabetes mellitus. J Diabetes Res, 2016: 1269706.


  1. Alberti KG, Johnston DG, Gill A, et al., 1978, Hormonal regulation of ketone-body metabolism in man. Biochem Soc Symp, 43: 163–182.


  1. Kroll MH, Elin RJ, 1985, Relationships between magnesium and protein concentrations in serum. Clin Chem, 31(2): 244–246.


  1. Paunier L, 1992, Effect of magnesium on phosphorus and calcium metabolism. Monatsschr Kinderheilkd, 140(9 Suppl 1): S17–S20.


  1. Jeon US, 2008, Kidney and calcium homeostasis. Electrolyte Blood Press, 6(2): 68–76.


  1. Guerrero-Romero F, Mercado M, Rodriguez-Moran M, et al., 2022, Magnesium-to-calcium ratio and mortality from COVID-19. Nutrients, 14(9): 1686.


  1. Coman AE, Ceasovschih A, Petroaie AD, et al., 2023, The significance of low magnesium levels in COVID-19 patients. Medicina (Kaunas), 59: 279.


  1. Agarwal R, Davis JL, Smith L, 2008, Serum albumin is strongly associated with erythropoietin sensitivity in hemodialysis patients. Clin J Am Soc Nephrol, 3(1): 98–104.


  1. Johnson KD, Laoveeravat P, Yee EU, et al., 2020, Endoscopic ultrasound guided liver biopsy: Recent evidence. World J Gastrointest Endosc, 12(3): 83–97.


  1. Farmer TD, Jenkins EC, O’Brien TP, et al., 2015, Comparison of the physiological relevance of systemic vs. portal insulin delivery to evaluate whole body glucose flux during an insulin clamp. Am J Physiol Endocrinol Metab, 308(3): E206–E222.
Conflict of interest
The authors declare no conflicts of interest.
Back to top
Gene & Protein in Disease, Electronic ISSN: 2811-003X Published by AccScience Publishing